Haemonetics (HAE) Gross Margin (2009 - 2026)

Haemonetics' Gross Margin history runs 18 years deep, the most recent figure standing at 57.23% for Q1 2026.

• In Q1 2026, Gross Margin fell 117.0% year-over-year to 57.23%; the TTM figure through Mar 2026 stood at 59.04% (up 400.0% YoY), while the FY2026 annual figure was 59.04%, up 400.0% from the prior year.
• Gross Margin was 57.23% for Q1 2026 at Haemonetics, down from 59.71% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 59.82% in Q2 2025 to a low of 51.24% in Q1 2024.
• Historically, Gross Margin has averaged 54.64% across 5 years, with a median of 53.66% in 2023.
• The sharpest annual moves came in 2022 and 2024: Gross Margin jumped 1508 bps in 2022, then tumbled 169 bps in 2024.
• A 5-year view of Gross Margin shows it stood at 51.98% in 2022, then climbed by 2 bps to 52.9% in 2023, then gained by 5 bps to 55.53% in 2024, then grew by 8 bps to 59.71% in 2025, then fell by 4 bps to 57.23% in 2026.
• The last three Gross Margin figures came in at 57.23% (Q1 2026), 59.71% (Q4 2025), and 59.5% (Q3 2025), per Business Quant data.